Average Co-Inventor Count = 2.01
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Syndevrx, Inc. (15 from 19 patents)
2. Geltex Pharmaceuticals, Inc. (12 from 64 patents)
3. Genzyme Corporation (9 from 790 patents)
4. Millipore Corporation (2 from 468 patents)
5. Waters Investments Limited (1 from 137 patents)
6. Nitric Biotherapeutics, Inc. (1 from 3 patents)
7. Waters Corporation (9 patents)
40 patents:
1. 11304944 - MetAP2 inhibitors and methods of treating obesity
2. 10722532 - Polymer-conjugated METAP2 inhibitors, and therapeutic methods of use thereof
3. 10588904 - METAP2 inhibitors and methods of treating obesity
4. 10287277 - Fumagillol derivatives and polymorphs thereof
5. 10159692 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
6. 10010544 - METAP2 inhibitors and methods of treating obesity
7. 9969722 - Fumagillol derivatives and polymorphs thereof
8. 9931358 - Direct compression polymer tablet core
9. 9895449 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
10. 9757373 - MetAP2 inhibitors and methods of treating obesity
11. 9750737 - METAP2 inhibitors and methods of treating obesity
12. 9730955 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
13. 9585909 - Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
14. 9579343 - Direct compression polymer tablet core
15. 9433600 - METAP2 inhibitors and methods of treating obesity